Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 9546

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.


Publication type: Journal Article

Manasse HR Jr.
Medication use in an imperfect world: drug misadventuring as an issue of public policy, Part 2.
Am J Hosp Pharm 1989 Jun; 46:(6):1141-52


Factors involved in adverse or toxic effects related to errors in drug use or to immunological or idiosyncratic responses to drug therapy are presented; the impact of forces in the social, economic, political, and scientific-technological environments defining the American society and the role of patients (drug users), drug manufacturers, pharmacists (drug distributors), prescribers, third party payers, and policy makers within these forces on drug utilization and the incidence of drug misadventuring in the United States are discussed.

Drug Industry/standards Drug Therapy* Economics, Pharmaceutical Environment Pharmaceutical Preparations/adverse effects* Pharmacy/trends* Prescriptions, Drug Public Policy* Technology, Pharmaceutical United States


  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Click to Register

(read more)

Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts

If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.